These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1950741)

  • 1. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    Adv Exp Med Biol; 1991; 290():119-28; discussion 129-32. PubMed ID: 1950741
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
    Hofmann T; Senier I; Bittner P; Hüls G; Schwandt HJ; Lindemann H
    J Aerosol Med; 1997; 10(2):147-58. PubMed ID: 10168532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pilot study of amiloride inhalation in children with cystic fibrosis].
    Riedler J; Huttegger I
    Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
    Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial.
    Bowler IM; Kelman B; Worthington D; Littlewood JM; Watson A; Conway SP; Smye SW; James SL; Sheldon TA
    Arch Dis Child; 1995 Nov; 73(5):427-30. PubMed ID: 8554360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients. The Amiloride-AFLM Collaborative Study Group.
    Pons G; Marchand MC; d'Athis P; Sauvage E; Foucard C; Chaumet-Riffaud P; Sautegeau A; Navarro J; Lenoir G
    Pediatr Pulmonol; 2000 Jul; 30(1):25-31. PubMed ID: 10862159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    N Engl J Med; 1990 Oct; 323(14):996-8. PubMed ID: 2402269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Elimination of secretions in CF patients under amiloride inhalation].
    Lindemann H; Becker T; Bittner P; Boldt A; Hofmann T; Schwandt HJ
    Pneumologie; 1990 Oct; 44(10):1148-50. PubMed ID: 2281055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of inhaled amiloride in cystic fibrosis.
    Viaca A; Bignamini E
    Lancet; 1996 Apr; 347(9008):1126. PubMed ID: 8602105
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
    Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiloride inhalation therapy in mucoviscidosis].
    Lindemann H
    Monatsschr Kinderheilkd; 1993 May; 141(5):392-4. PubMed ID: 8326957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC; McElvaney NG; Birrer P; Shak S; Robinson WW; Jolley C; Wu M; Chernick MS; Crystal RG
    N Engl J Med; 1992 Mar; 326(12):812-5. PubMed ID: 1538726
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Hofmann T; Stutts MJ; Ziersch A; Rückes C; Weber WM; Knowles MR; Lindemann H; Boucher RC
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1844-9. PubMed ID: 9620916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH; O'Doherty MJ; Graham A; Page CJ; Blower P; Geddes DM; Nunan TO
    Thorax; 1991 Oct; 46(10):717-21. PubMed ID: 1750018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.
    Snyder AH; McPherson ME; Hunt JF; Johnson M; Stamler JS; Gaston B
    Am J Respir Crit Care Med; 2002 Apr; 165(7):922-6. PubMed ID: 11934715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiloride inhalation].
    Lindemann H
    Pneumologie; 1996 Dec; 50 Suppl 3():841-4. PubMed ID: 9157440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.